Yifan Yang

Yifan Yang is involved in procurement activities focused on specialized scientific and medical acquisitions. Their work supports the agency's mission through the acquisition of high-tech research and manufacturing capabilities. Regarding set-aside preferences, the available data indicates that 100% of acquisitions are categorized as No Set-Aside, suggesting a focus on full and open competition for these requirements. The procurement focus is heavily weighted toward the life sciences and biotechnology sectors. Primary technical expertise is concentrated in Research and Development in Biotechnology, with significant activity in pharmaceutical and biological product manufacturing. Additionally, the portfolio includes the procurement of surgical appliances and supplies, as well as services related to blood and organ banks.